DNER and lymphoma: There was a synergistic effect of BET inhibitor JQ1 and anti-PD-1 antibody in a mouse model of Eμ-Myc lymphoma, providing evidence for the relevance of combining BET inhibitors and immune checkpoint inhibitors [108].